Pictet Asset Management (UK)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $168M | Buy |
|
|||||
|
2021
Q1 | $152M | Sell |
|
|||||
|
2020
Q4 | $163M | Buy |
|
|||||
|
2020
Q3 | $128M | Buy |
|
|||||
|
2020
Q2 | $159M | Buy |
|
|||||
|
2020
Q1 | $78.3M | Buy |
|
|||||
|
2019
Q4 | $92M | Sell |
|
|||||
|
2019
Q3 | $93.8M | Buy |
|
|||||
|
2019
Q2 | $80.2M | Sell |
|
|||||
|
2019
Q1 | $86.3M | Buy |
|
|||||
|
2018
Q4 | $67.1K | Buy |
|
|||||
|
2018
Q3 | $108M | Sell |
|
|||||
|
2018
Q2 | $90M | Sell |
|
|||||
|
2018
Q1 | $77.9M | Sell |
|
|||||
|
2017
Q4 | $87M | Sell |
|
|||||
|
2017
Q3 | $82.5M | Buy |
|
|||||
|
2017
Q2 | $49.6M | Buy |
|
|||||
|
2017
Q1 | $44M | Buy |
|
|||||
|
2016
Q4 | $30.3M | Buy |
|
|||||
|
2016
Q3 | $35.3M | Sell |
|
|||||
|
2016
Q2 | $35M | Buy |
|
|||||
|
2016
Q1 | $7.06M | Buy |
|
|||||
|
2015
Q4 | $8.59M | Buy |
|
|||||
|
2015
Q3 | $1.09M | Buy |
|